There have been no open-market insider trades at bluebird bio, Inc. in the last 12 months.
Looking at the quarterly pattern: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
There have been no open-market insider trades at bluebird bio, Inc. in the last 12 months.
Looking at the quarterly pattern: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Mar 5, 2025 | Colvin Richard A | Executive Officer | Sell | 584 | $3.92 | $2K | SEC |
| Mar 5, 2025 | Klima Thomas J | Officer | Sell | 500 | $3.92 | $2K | SEC |
| Mar 5, 2025 | Obenshain Andrew | CEO | Sell | 921 | $3.92 | $4K | SEC |
| Feb 5, 2025 | Klima Thomas J | Officer | Sell | 122 | $7.39 | $902 | SEC |
| Feb 5, 2025 | Colvin Richard A | Executive Officer | Sell | 64 | $7.39 | $473 | SEC |
| Feb 5, 2025 | Vittiglio Joseph | Executive Officer | Sell | 238 | $7.39 | $2K | SEC |
| Feb 5, 2025 | Obenshain Andrew | CEO | Sell | 86 | $7.39 | $636 | SEC |
| Jan 8, 2025 | Colvin Richard A | Executive Officer | Sell | 19 | $9.24 | $176 | SEC |
| Jan 8, 2025 | Obenshain Andrew | CEO | Sell | 140 | $9.24 | $1K | SEC |
| Dec 12, 2024 | Obenshain Andrew | CEO | Sell | 971 | $0.42 | $408 | SEC |
| Dec 12, 2024 | Colvin Richard A | Executive Officer | Sell | 2,824 | $0.42 | $1K | SEC |
| Oct 2, 2024 | Klima Thomas J | Officer | Sell | 1,006 | $0.53 | $533 | SEC |
| Oct 2, 2024 | Obenshain Andrew | CEO | Sell | 34,780 | $0.53 | $18K | SEC |
| Jun 4, 2024 | Klima Thomas J | Officer | Sell | 3,834 | $0.97 | $4K | SEC |
| Mar 5, 2024 | Colvin Richard A | Executive Officer | Sell | 6,770 | $1.53 | $10K | SEC |
There were no open-market insider trades in BLUE in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
No congressional trades in BLUE were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).